WebApr 10, 2024 · Summary. Duality Biologics (Suzhou) out-licensed global rights (ex-China) for two ADC candidates to BioNTech in a deal worth $170 million upfront and up to $1.5 … WebApr 10, 2024 · Summary. Duality Biologics (Suzhou) out-licensed global rights (ex-China) for two ADC candidates to BioNTech in a deal worth $170 million upfront and up to $1.5 billion in milestone payments.
BioNTech expands in Asia with China COVID vaccine JV and
WebJun 16, 2024 · China has a say in Taiwan’s inoculation campaign because BioNTech last year teamed up with a Shanghai company, Fosun Pharma, to distribute its Covid vaccine in mainland China, Hong Kong, Macau ... WebNov 4, 2024 · New hope China may soften on Covid boosts our stocks most tied to world’s No. 2 economy. Published Fri, Nov 4 20242:20 PM EDT. Kevin Stankiewicz @kevin_stank. The Nasdaq has a “very, very ... csl knoxville
China relaxes border restrictions for those who received China ... - CNBC
WebJan 11, 2024 · German BioNTech firm said an approval of its COVID-19 vaccine in China was still "extremely important" though predicting a conclusion of the regulatory review … WebNov 22, 2024 · November 22, 2024. Bloomberg. China is considering a potential emergency approval of BioNTech SE’s COVID-19 vaccine to make it available to foreigners living in the country, the company’s Chief Operating Officer Sierk Poetting said. Government-level discussions are still at an early stage and BioNTech hasn’t been involved yet, Poetting ... WebDec 14, 2024 · Yet, as more and more markets began to approve BioNTech’s jab in late 2024 and early 2024, it became clear that China’s government was dragging its feet on approval, spelling trouble for Fosun ... eagle rock activity center